ARTICLE | Company News
Aegis Therapeutics, Biodel deal
June 18, 2012 7:00 AM UTC
Aegis granted Biodel an exclusive, worldwide license to ProTek and Intravail technologies to develop and commercialize pharmaceutical formulations of glucagon. ProTek uses specific excipients as prot...